On Tuesday, JPMorgan Chase & Co.(NYSE:JPM)’s shares declined -0.88% to $60.91.
Chase Card Services, a division of JPMorgan Chase & Co. [JPM], Visa Inc. and United Airlines declared the extension of the popular United MileagePlus® credit card program. The multi-year agreements extend the more than 20-year legacy of providing exceptional benefits tailored for consumer and business card members.
This extension will continue offering a rich credit card program across multiple products counting the United MileagePlus® Explorer, United MileagePlus® Explorer Business and United MileagePlus® Club cards. Additionally, cardmembers will continue to enjoy access to exclusive events with InsideAccess.com in addition to exclusive luxury hotel and resort privileges.
AES Corp(NYSE:AES)’s shares dropped -2.78% to $10.48.
The AES Corporation (AES) was named to the Dow Jones Sustainability Index (DJSI) for North America for the second year in a row.
The DJSI is based on the Corporate Sustainability Assessment conducted by RobecoSAM. The annual assessment determines which companies are better equipped to respond to emerging opportunities and risks resulting from global sustainability trends.
For the first time this year, AES’ partner in Chile, AES Gener, take part in RobecoSAM’s annual Corporate Sustainability Assessment. AES Gener received the highest rating among all electric utilities for the Environmental Policy/Administration System category.
The AES Corporation operates as a diversified power generation and utility company. It owns and/or operates power plants to generate and sell power to customers, such as utilities, industrial users, and other intermediaries.
At the end of Tuesday’s trade, Medtronic PLC(NYSE:MDT)‘s shares dipped -0.14% to $70.14.
Medtronic plc (MDT) declared the U.S. launch of the Arc(TM) support catheter, the most navigable, 6F tapered support catheter accessible. Developed to improve delivery of Medtronic`s Solitaire(TM) stent retriever, the Arc support catheter provides the fastest route to restoration of blood flow in patients with complex anatomy suffering acute ischemic stroke.1,2,3 The Arc catheter series received U.S. Food and Drug Administration 510(K) clearance in July 2015.
Recently, the American Heart Association/American Stroke Association (AHA/ASA) published new stroke treatment guidelines that recommend the use of stent retriever technology - such as Medtronic`s Solitaire stent retriever device - in conjunction with the current standard of care, IV-tPA for eligible patients. The AHA/ASA guidelines are based on a panel of experts` analysis of the results from five global clinical trials published in The New England Journal of Medicine (NEJM) that found the addition of stent retriever technology, a surgical procedure that manually removes blood clots from the brain, to current medical therapy such as IV-tPA, has a therapeutic benefit over medical therapy alone.
Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators, implantable cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, and peripheral vascular intervention products.
Fitbit Inc(NYSE:FIT), ended its Tuesday’s trading session with 3.81% gain, and closed at $39.54.
Fitbit, Inc., the leader in the connected health and fitness market, declared that it supports HIPAA compliance, enabling Fitbit Wellness to more effectively integrate with HIPAA-covered entities, counting corporate wellness partners, health plans and self-insured employers. The U.S. Health Insurance Portability and Accountability Act (HIPAA) is the primary U.S. law governing the security and privacy of personal health information used by health insurance plans and other covered entities.
A Big Step Forward for Fitbit Wellness
Fitbit’s HIPAA compliance program provides added value to new and existing customers for Fitbit Wellness, the company’s business-to-business offering that provides turnkey software and services to assist organizations drive engaging, effective and motivating wellness programs.
- The HIPAA compliance program will enable Fitbit Wellness to better support HIPAA-covered entities that are looking to improve the health and wellness of their members and employees.
- Fitbit Wellness will be able to expand integration opportunities with health plans and self-insured employers by its ability to enter into Business Associate Agreements with HIPAA-covered entities.
Fitbit Inc. manufactures and provides wearable fitness-tracking devices worldwide. The company makes both wrist bands and clippable devices that monitor a user’s fitness activity by tracking the calories burned or distance covered.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
